1. 1,2,3,4-tetrahydro-2-methyl-9h-dibenzo(3,4-6,7)cyclohepta(1,2-c)pyridine
2. 13b,4a-carba-mianserin
3. Mo 8282
4. Mo-8282
5. Org 8282
6. Org-8282
1. 57262-94-9
2. Org-8282
3. Setiptiline [inn]
4. Org 8282
5. Mo 8282
6. 2,3,4,9-tetrahydro-2-methyl-1h-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine
7. Setiptiline (inn)
8. 4-methyl-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),2(7),8,10,12,15,17-heptaene
9. 7l38105z6e
10. Setiptilinum [latin]
11. Setiptilina [spanish]
12. Setiptilina
13. Setiptilinum
14. 2,3,4,9-tetrahydro-2-methyl-1h-dibenzo(3,4:6,7)cyclohepta(1,2-c)pyridine
15. 1h-dibenzo(3,4:6,7)cyclohepta(1,2-c)pyridine, 2,3,4,9-tetrahydro-2-methyl-
16. Einecs 260-653-4
17. Brn 1650422
18. Unii-7l38105z6e
19. 1h-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine, 2,3,4,9-tetrahydro-2-methyl-
20. Tecipul [as Maleate]
21. Setiptiline [mi]
22. Setiptiline [mart.]
23. Setiptiline [who-dd]
24. Schembl211362
25. Chembl2104895
26. Dtxsid50205886
27. Chebi:135076
28. Zinc1482169
29. Cs-1181
30. Db09304
31. Ncgc00378937-01
32. Ncgc00378937-02
33. Org 8282;org8282;org-8282
34. Hy-32329
35. Ft-0674569
36. D08511
37. 262s949
38. A923887
39. L003337
40. Q6590424
41. 1,2,3,4-tetrahydro-2-methyl-1h-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine
42. 2-methyl-2,3,4,9-tetrahydro-1h-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine
43. 4-methyl-4-azatetracyclo[13.4.0.0^{2,7.0^{8,13]nonadeca-1(19),2(7),8,10,12,15,17-heptaene
Molecular Weight | 261.4 g/mol |
---|---|
Molecular Formula | C19H19N |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 261.151749610 g/mol |
Monoisotopic Mass | 261.151749610 g/mol |
Topological Polar Surface Area | 3.2 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 397 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of depression.
Setiptiline is a tertacyclic antidepressant. It acts to reduce the symptoms of major depressive disorder.
Setiptiline is an antagonist at the 2 adrenergic receptor and at serotonin receptors. The antagonism of the 2 receptors likely relieves presynaptic inhibition of adrenergic neurotransmission, allowing for greater and longer sustained release of noradrenaline into the synapse. The antagonism of serotonin receptors may produce an upregulation of the receptors leading to an eventual increase in serotonergic signalling. The actual physiological mechanisms behind the antidepressant effect of setiptiline is unknown but the listed possibilities exist as likely explanations.